
Hema Bansal
About Hema Bansal
Data last updated:
Hema Bansal is a Director at Sony Impex Private Limited (since 2020) and Director at Sigma Bio-Sciences Private Limited (since 2020). The companies operate in Healthcare and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹17.3 Lakh; the largest is Sony Impex Private Limited at ₹14 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Jun 2020 | 2005 | ₹14 Lakh (FY 2017) | Active | |
| Director | 08 Jun 2020 | 1993 | ₹3.3 Lakh (FY 2017) | Active |
Board colleagues of Hema Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Munish Bansal | 00103487 | Sony Impex Private Limited , Sigma Bio-Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hema Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hema Bansal
Hema Bansal currently holds 2 directorships: Sony Impex Private Limited (Director, since 08 Jun 2020, revenue ₹14 Lakh (FY 2017)); Sigma Bio-Sciences Private Limited (Director, since 08 Jun 2020, revenue ₹3.3 Lakh (FY 2017)).
Hema Bansal was first appointed on 08 Jun 2020 as Director at Sony Impex Private Limited.
The 2 current companies of Hema Bansal that report revenue have a combined latest revenue of ₹17.3 Lakh: Sony Impex Private Limited ₹14 Lakh (FY 2017); Sigma Bio-Sciences Private Limited ₹3.3 Lakh (FY 2017).
The current boards of Hema Bansal's companies include Munish Bansal (Sony Impex Private Limited).